Literature DB >> 2068138

Response of neuroblastoma to retinoic acid in vitro and in vivo.

C P Reynolds1, D J Kane, P A Einhorn, K K Matthay, V L Crouse, J R Wilbur, S B Shurin, R C Seeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2068138

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  31 in total

Review 1.  [Neuroblastoma].

Authors:  Victoria Castel; Adela Cañete; Rosa Noguera; Samuel Navarro; Silvestre Oltra
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

2.  Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.

Authors:  Robin E Norris; Jane E Minturn; Garrett M Brodeur; John M Maris; Peter C Adamson
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-12       Impact factor: 3.333

Review 3.  Neuroblastoma.

Authors:  Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2012-02       Impact factor: 2.754

4.  Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.

Authors:  Surajit Karmakar; Subhasree Roy Choudhury; Naren L Banik; Swapan K Ray
Journal:  J Cancer Sci Ther       Date:  2010-06-26

5.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

6.  Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells.

Authors:  Manrong Jiang; Kejin Zhu; Jose Grenet; Jill M Lahti
Journal:  Biochim Biophys Acta       Date:  2008-03-10

7.  Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.

Authors:  Arabinda Das; Naren L Banik; Swapan K Ray
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

8.  Biological therapy for pediatric malignancy: current perspectives.

Authors:  Bharat Agarwal
Journal:  Indian J Pediatr       Date:  2008-08       Impact factor: 1.967

9.  Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.

Authors:  Katherine K Matthay
Journal:  Clin Cancer Res       Date:  2012-12-03       Impact factor: 12.531

10.  Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.

Authors:  Poonam Sonawane; Hwang Eui Cho; Ashujit Tagde; Dattesh Verlekar; Alice L Yu; C Patrick Reynolds; Min H Kang
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.